Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: Effects on sensorimotor gating

Behavioural Brain Research

Volumn 230, Issue 1, 2012, Pages 243-250

  Lindemann, Christoph ^a   Krauss, Joachim K ^a   Schwabe, Kerstin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apomorphine; Deep brain stimulation; Parkinson's disease; Prepulse inhibition; Subthalamic nucleus

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ELECTRODE; MALE; MONOTHERAPY; MOTOR PERFORMANCE; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THERAPY EFFECT;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; GAIT DISORDERS, NEUROLOGIC; INHIBITION (PSYCHOLOGY); MALE; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SUBTHALAMIC NUCLEUS; SYMPATHOLYTICS;

EID: 84857741909     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.02.009     Document Type: Article

References (65)

1. Gale J.T., Amirnovin R., Williams Z.M., Flaherty A.W., Eskandar E.N. From symphony to cacophony: pathophysiology of the human basal ganglia in Parkinson disease. Neurosci Biobehav Rev 2008, 32:378-387.
2. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temiño B., Mena-Segovia J., et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 2008, 64(Suppl. 2):S30-S46.
3. Rodriguez-Oroz M.C., Jahanshahi M., Krack P., Litvan I., Macias R., Bezard E., et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009, 8:1128-1139.
4. Benabid A.L., Chabardes S., Mitrofanis J., Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009, 8:67-81.
5. Bronstein J.M., Tagliati M., Alterman R.L., Lozano A.M., Volkmann J., Stefani A., et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011, 68:165.
6. Park A., Stacy M. Non-motor symptoms in Parkinson's disease. J Neurol 2009, 256(Suppl. 3):293-298.
7. Weintraub D., Burn D.J. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011, 26:1022-1031.
8. Fénelon G., Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci 2010, 289:12-17.
9. Diederich N.J., Goetz C.G., Stebbins G.T. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005, 20:130-140.
10. Umemura A., Oka Y., Okita K., Matsukawa N., Yamada K. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions. J Neurosurg 2011, 114:1701-1705.
11. Herzog J., Reiff J., Krack P., Witt K., Schrader B., Müller D., et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord 2003, 18:1382-1384.
12. Diederich N.J., Alesch F., Goetz C.G. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol 2000, 23:287-289.
13. Burn D.J., Tröster A.I. Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease. J Geriatr Psychiatry Neurol 2004, 17:172-180.
14. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006, 12:265-272.
15. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990, 47:181-188.
16. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998, 24:285-301.
17. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 2001, 49:171-178.
18. Hoenig K., Hochrein A., Quednow B.B., Maier W., Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 2005, 57:1153-1158.
19. Baldan Ramsey L.C., Xu M., Wood N., Pittenger C. Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 2011, 180:222-228.
20. Lütjens G., Krauss J.K., Schwabe K. Lesions of the entopeduncular nucleus in rats prevent apomorphine-induced deficient sensorimotor gating. Behav Brain Res 2011, 220:281-287.
21. Bowe A., Lindemann C., Friedrich S., Krauss J.K., Schwabe K. Disturbed behavioral function and enhanced sensitivity for psychoactive drugs in the rat 6-hydroxydopamine Parkinson model. Mov Disord 2009, 24(Suppl. 1):236.
22. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 2002, 175:303-317.
23. Voorn P., Vanderschuren L.J.M.J., Groenewegen H.J., Robbins T.W., Pennartz C.M.A. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 2004, 27:468-474.
24. Lane E.L., Carlsson T., Kirik D., Dunnett S.B. Animal models of Parkinson's disease. Sourcebook of Models for Biomedical Research 2008, 313-322. Humana Press, Totowa, NJ. P.M. Conn (Ed.).
25. Rauch F., Schwabe K., Krauss J.K. Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model. Behav Brain Res 2010, 210:46-53.
26. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
27. Rödter A., Winkler C., Samii M., Nikkhah G. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant 2000, 9:197-214.
28. Metz G.A., Piecharka D.M., Kleim J.A., Whishaw I.Q. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease. Brain Res 2004, 1026:126-135.
29. Martinez-Torres I., Hariz M.I., Zrinzo L., Foltynie T., Limousin P. Improvement of tics after subthalamic nucleus deep brain stimulation. Neurology 2009, 72:1787-1789.
30. Mallet L., Polosan M., Jaafari N., Baup N., Welter M.L., Fontaine D., et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008, 359:2121-2134.
31. Berney A., Vingerhoets F., Perrin A., Guex P., Villemure J.-G., Burkhard P.R., et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002, 59:1427-1429.
32. Doshi P.K., Chhaya N., Bhatt M.H. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002, 17:1084-1085.
33. Houeto J.L., Mesnage V., Mallet L., Pillon B., Gargiulo M., du Moncel S.T., et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:701-707.
34. Voon V., Kubu C., Krack P., Houeto J-L., Tröster A.I. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006, 21(Suppl. 14):S305-S327.
35. Soulas T., Gurruchaga J-M., Palfi S., Cesaro P., Nguyen J-P., Fénelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry 2008, 79:952-954.
36. Gervais-Bernard H., Xie-Brustolin J., Mertens P., Polo G., Klinger H., Adamec D., et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009, 256:225-233.
37. Molinuevo J.L., Valldeoriola F., Tolosa E., Rumia J., Valls-Sole J., Roldan H., et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000, 57:983-988.
38. Krack P., Fraix V., Mendes A., Benabid A-L., Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002, 17(Suppl 3):S188-S197.
39. Witt K., Daniels C., Herzog J., Lorenz D., Volkmann J., Reiff J., et al. Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2006, 18:397-401.
40. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 1986, 21:23-33.
41. Kretschmer B.D., Koch M. The ventral pallidum mediates disruption of prepulse inhibition of the acoustic startle response induced by dopamine agonists, but not by NMDA antagonists. Brain Res 1998, 798:204-210.
42. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
43. Schicatano E.J., Peshori K.R., Gopalaswamy R., Sahay E., Evinger C. Reflex excitability regulates prepulse inhibition. J Neurosci 2000, 20:4240-4247.
44. Valls-Solé J. Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system. Clin Neurophysiol 2005, 116:2255-2265.
45. Morton N., Chaudauri R., Ellis C., Gray N.S., Toone B.K. The effect of apomorphine and L-dopa challenge on prepulse inhibition in patients with parkinsons disease. Schizophr Res 1995, 15:181-182.
46. Kimura J. Disorder of interneurons in Parkinsonism. The orbicularis oculi reflex to paired stimuli. Brain 1973, 96:87-96.
47. Nakashima K., Shimoyama R., Yokoyama Y., Takahashi K. Auditory effects on the electrically elicited blink reflex in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol 1993, 89:108-112.
48. Costa J., Valls-Solé J., Valldeoriola F., Pech C., Rumià J. Single subthalamic nucleus deep brain stimuli inhibit the blink reflex in Parkinson's disease patients. Brain 2006, 129:1758-1767.
49. Chang J.Y., Shi L.H., Luo F., Woodward D.J. High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats. Brain Res 2003, 983:174-184.
50. Brown A.R., Antle M.C., Hu B., Teskey G.C. High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats. Exp Neurol 2011, 231:82-90.
51. Jouve L., Salin P., Melon C., Kerkerian-Le Goff L. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease. J Neurosci 2010, 30:9919-9928.
52. Drapier D., Drapier S., Sauleau P., Haegelen C., Raoul S., Biseul I., et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease. J Neurol 2006, 253:1083-1091.
53. Mallet L., Schüpbach M., N'Diaye K., Remy P., Bardinet E., Czernecki V., et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci USA 2007, 104:10661-10666.
54. Greenhouse I., Gould S., Houser M., Hicks G., Gross J., Aron A.R. Stimulation at dorsal and ventral electrode contacts targeted at the subthalamic nucleus has different effects on motor and emotion functions in Parkinson's disease. Neuropsychologia 2011, 49:528-534.
55. Chaudhuri K.R., Yates L., Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005, 5:275-283.
56. Temel Y., Blokland A., Steinbusch H.W.M., Visser-Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005, 76:393-413.
57. Kopell B.H., Greenberg B., Rezai A.R. Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol 2004, 21:51-67.
58. Hamani C., Saint-Cyr J.A., Fraser J., Kaplitt M., Lozano A.M. The subthalamic nucleus in the context of movement disorders. Brain 2004, 127:4-20.
59. Florio T., Scarnati E., Confalone G., Minchella D., Galati S., Stanzione P., et al. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. Eur J Neurosci 2007, 25:1174-1186.
60. Weintraub D., Morales K.H., Duda J.E., Moberg P.J., Stern M.B. Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism Relat Disord 2006, 12:427-431.
61. Kodsi M.H., Swerdlow N.R. Regulation of prepulse inhibition by ventral pallidal projections. Brain Res Bull 1997, 43:219-228.
62. Lozano A.M., Dostrovsky J., Chen R., Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 2002, 1:225-231.
63. Vitek J.L. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 2002, 17(Suppl. 3):S69-S72.
64. Hashimoto T., Elder C.M., Okun M.S., Patrick S.K., Vitek J.L. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003, 23:1916-1923.
65. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 1999, 23:743-760.